FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Penicillin G Benzathine Injection
Status: Currently in Shortage
»Date first posted: 04/26/2023
»Therapeutic Categories: Anti-Infective

Expand all

Laboratoires Delbert (Revised 07/24/2024)

Company Contact Information:
Provepharm: 833-727-6556

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Extencilline, Injection, 1,200,000 units (NDC 81284-521-01)	Available	Dear Healthcare Provider Letter: Temporary Importation of Extencilline, (benzathine benzylpenicillin) Powder and diluent for reconstitution for injection, 1,200,000 units and 2,400,000 units with Foreign, non-U.S. Labeling to Address Supply Shortage (HYPERLINK) Instruction on how to prepare and administer Extencilline (HYPERLINK)
Extencilline, Injection, 2,400,000 units (NDC 81284-522-01)	Available	Dear Healthcare Provider Letter: Temporary Importation of Extencilline, (benzathine benzylpenicillin) Powder and diluent for reconstitution for injection, 1,200,000 units and 2,400,000 units with Foreign, non-U.S. Labeling to Address Supply Shortage (HYPERLINK) Instruction on how to prepare and administer Extencilline

Laboratorios Atral (Revised 09/24/2024)

Company Contact Information:
Mark Cuban Cost Plus Drug Company: 682-428-8081

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01)	Available	Dear Healthcare Provider Letter: Temporary Importation of Lentocilin©, (Benzathine Benzylpenicillin Tetrahydrate) Powder and diluent for suspension for injection, 1,200,000 units with Foreign, non-U.S. Labeling to Address Supply Shortage (HYPERLINK)

Pfizer Inc. (Revised 11/14/2024)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Bicillin L-A, Injection, 600000 [iU]/1 mL (NDC 60793-700-10)	Unavailable	Next Delivery: February 2025; Estimated Recovery: March 2025	Other
Bicillin L-A, Injection, 1200000 [iU]/2 mL (NDC 60793-701-10)	Available
Bicillin L-A, Injection, 2400000 [iU]/4 mL (NDC 60793-702-10)	Limited Availability	Limited Supply Available. Next Delivery: November 2024; Estimated Recovery: December 2024	Other